Metabolomics Workbench : NIH Data Repository

Return to study ST002078 main page

Download data matrix(Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Reversed phase NEGATIVE ION MODE)

Analysis	Samples	Factors	Units
Reversed phase NEGATIVE ION MODE	Blank1	Drug:Blank	peak area
Reversed phase NEGATIVE ION MODE	Blank2	Drug:Blank	peak area
Reversed phase NEGATIVE ION MODE	Blank3	Drug:Blank	peak area
Reversed phase NEGATIVE ION MODE	Halofuginone1	Drug:Halofuginone	peak area
Reversed phase NEGATIVE ION MODE	Halofuginone2	Drug:Halofuginone	peak area
Reversed phase NEGATIVE ION MODE	Halofuginone3	Drug:Halofuginone	peak area
Reversed phase NEGATIVE ION MODE	MMV1081413_1	Drug:MMV1081413	peak area
Reversed phase NEGATIVE ION MODE	MMV1081413_2	Drug:MMV1081413	peak area
Reversed phase NEGATIVE ION MODE	MMV1081413_3	Drug:MMV1081413	peak area
Reversed phase NEGATIVE ION MODE	MMV1091186_1	Drug:MMV1091186	peak area
Reversed phase NEGATIVE ION MODE	MMV1091186_2	Drug:MMV1091186	peak area
Reversed phase NEGATIVE ION MODE	MMV1091186_3	Drug:MMV1091186	peak area
Reversed phase NEGATIVE ION MODE	ND1	Drug:ND	peak area
Reversed phase NEGATIVE ION MODE	ND2	Drug:ND	peak area
Reversed phase NEGATIVE ION MODE	ND3	Drug:ND	peak area
Reversed phase NEGATIVE ION MODE	Pool1	Drug:Pool	peak area
Reversed phase NEGATIVE ION MODE	Pool2	Drug:Pool	peak area
Reversed phase NEGATIVE ION MODE	Pool3	Drug:Pool	peak area
Reversed phase NEGATIVE ION MODE	Blank1	Drug:Blank	peak area
Reversed phase NEGATIVE ION MODE	Blank2	Drug:Blank	peak area
Reversed phase NEGATIVE ION MODE	Blank3	Drug:Blank	peak area
Reversed phase NEGATIVE ION MODE	MMV1578884_1	Drug:MMV1578884	peak area
Reversed phase NEGATIVE ION MODE	MMV1578884_2	Drug:MMV1578884	peak area
Reversed phase NEGATIVE ION MODE	MMV1578884_3	Drug:MMV1578884	peak area
Reversed phase NEGATIVE ION MODE	ND1	Drug:ND	peak area
Reversed phase NEGATIVE ION MODE	ND2	Drug:ND	peak area
Reversed phase NEGATIVE ION MODE	ND3	Drug:ND	peak area
Reversed phase NEGATIVE ION MODE	Pool1	Drug:Pool	peak area
Reversed phase NEGATIVE ION MODE	Pool2	Drug:Pool	peak area
Reversed phase NEGATIVE ION MODE	Pool3	Drug:Pool	peak area
Reversed phase NEGATIVE ION MODE	Blank1	Drug:Blank	peak area
Reversed phase NEGATIVE ION MODE	Blank2	Drug:Blank	peak area
Reversed phase NEGATIVE ION MODE	Blank3	Drug:Blank	peak area
Reversed phase NEGATIVE ION MODE	ND1	Drug:ND	peak area
Reversed phase NEGATIVE ION MODE	ND2	Drug:ND	peak area
Reversed phase NEGATIVE ION MODE	ND3	Drug:ND	peak area
Reversed phase NEGATIVE ION MODE	OSM-S-106-1	Drug:OSM-S-106	peak area
Reversed phase NEGATIVE ION MODE	OSM-S-106-2	Drug:OSM-S-106	peak area
Reversed phase NEGATIVE ION MODE	OSM-S-106-3	Drug:OSM-S-106	peak area
Reversed phase NEGATIVE ION MODE	Pool1	Drug:Pool	peak area
Reversed phase NEGATIVE ION MODE	Pool2	Drug:Pool	peak area
Reversed phase NEGATIVE ION MODE	Pool3	Drug:Pool	peak area
Reversed phase NEGATIVE ION MODE	Blank2	Drug:Blank	peak area
Reversed phase NEGATIVE ION MODE	Blank3	Drug:Blank	peak area
Reversed phase NEGATIVE ION MODE	ND1	Drug:ND	peak area
Reversed phase NEGATIVE ION MODE	ND2	Drug:ND	peak area
Reversed phase NEGATIVE ION MODE	ND3	Drug:ND	peak area
Reversed phase NEGATIVE ION MODE	Pool1	Drug:Pool	peak area
Reversed phase NEGATIVE ION MODE	Pool2	Drug:Pool	peak area
Reversed phase NEGATIVE ION MODE	Pool3	Drug:Pool	peak area
Reversed phase NEGATIVE ION MODE	TCMDC-124553-1	Drug:TCMDC-124553	peak area
Reversed phase NEGATIVE ION MODE	TCMDC-124553-2	Drug:TCMDC-124553	peak area
Reversed phase NEGATIVE ION MODE	TCMDC-124553-3	Drug:TCMDC-124553	peak area